Logo image of ALISP.PA

ISPD NETWORK (ALISP.PA) Stock Fundamental Analysis

EPA:ALISP - ES0109429037 - Common Stock

1.99 EUR
-0.01 (-0.5%)
Last: 9/5/2025, 7:00:00 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to ALISP. ALISP was compared to 62 industry peers in the Media industry. ALISP has a bad profitability rating. Also its financial health evaluation is rather negative. ALISP is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year ALISP has reported negative net income.
ALISP had a negative operating cash flow in the past year.
In multiple years ALISP reported negative net income over the last 5 years.
The reported operating cash flow has been mixed in the past 5 years: ALISP reported negative operating cash flow in multiple years.
ALISP.PA Yearly Net Income VS EBIT VS OCF VS FCFALISP.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M

1.2 Ratios

ALISP's Return On Assets of -0.60% is on the low side compared to the rest of the industry. ALISP is outperformed by 61.29% of its industry peers.
ALISP has a worse Return On Equity (-9.85%) than 67.74% of its industry peers.
ALISP has a Return On Invested Capital (2.85%) which is comparable to the rest of the industry.
ALISP had an Average Return On Invested Capital over the past 3 years of 13.74%. This is significantly above the industry average of 7.82%.
The 3 year average ROIC (13.74%) for ALISP is well above the current ROIC(2.85%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA -0.6%
ROE -9.85%
ROIC 2.85%
ROA(3y)2.77%
ROA(5y)1.73%
ROE(3y)30.06%
ROE(5y)N/A
ROIC(3y)13.74%
ROIC(5y)14.58%
ALISP.PA Yearly ROA, ROE, ROICALISP.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 100 150

1.3 Margins

The Operating Margin of ALISP (0.45%) is worse than 66.13% of its industry peers.
ALISP's Operating Margin has declined in the last couple of years.
ALISP's Gross Margin of 31.54% is on the low side compared to the rest of the industry. ALISP is outperformed by 75.81% of its industry peers.
ALISP's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 0.45%
PM (TTM) N/A
GM 31.54%
OM growth 3Y-61.04%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-10.12%
GM growth 5Y-7.49%
ALISP.PA Yearly Profit, Operating, Gross MarginsALISP.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40 50

2

2. Health

2.1 Basic Checks

ALISP has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
Compared to 1 year ago, ALISP has about the same amount of shares outstanding.
Compared to 5 years ago, ALISP has more shares outstanding
ALISP has a worse debt/assets ratio than last year.
ALISP.PA Yearly Shares OutstandingALISP.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M
ALISP.PA Yearly Total Debt VS Total AssetsALISP.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

ALISP has an Altman-Z score of 2.30. This is not the best score and indicates that ALISP is in the grey zone with still only limited risk for bankruptcy at the moment.
The Altman-Z score of ALISP (2.30) is better than 79.03% of its industry peers.
ALISP has a Debt/Equity ratio of 1.10. This is a high value indicating a heavy dependency on external financing.
ALISP has a Debt to Equity ratio (1.10) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 1.1
Debt/FCF N/A
Altman-Z 2.3
ROIC/WACC0.45
WACC6.34%
ALISP.PA Yearly LT Debt VS Equity VS FCFALISP.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M 15M

2.3 Liquidity

ALISP has a Current Ratio of 0.95. This is a bad value and indicates that ALISP is not financially healthy enough and could expect problems in meeting its short term obligations.
ALISP has a Current ratio of 0.95. This is comparable to the rest of the industry: ALISP outperforms 46.77% of its industry peers.
A Quick Ratio of 0.95 indicates that ALISP may have some problems paying its short term obligations.
ALISP has a Quick ratio (0.95) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 0.95
Quick Ratio 0.95
ALISP.PA Yearly Current Assets VS Current LiabilitesALISP.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

5

3. Growth

3.1 Past

ALISP shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -116.55%.
The Revenue has grown by 11.47% in the past year. This is quite good.
Measured over the past years, ALISP shows a very strong growth in Revenue. The Revenue has been growing by 43.98% on average per year.
EPS 1Y (TTM)-116.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0.22%
Revenue 1Y (TTM)11.47%
Revenue growth 3Y13.88%
Revenue growth 5Y43.98%
Sales Q2Q%6.35%

3.2 Future

The Earnings Per Share is expected to grow by 216.23% on average over the next years. This is a very strong growth
ALISP is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.86% yearly.
EPS Next Y900%
EPS Next 2Y216.23%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year11.17%
Revenue Next 2Y10.79%
Revenue Next 3Y6.89%
Revenue Next 5Y4.86%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ALISP.PA Yearly Revenue VS EstimatesALISP.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 50M 100M 150M 200M
ALISP.PA Yearly EPS VS EstimatesALISP.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 0.2 0.4

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ALISP. In the last year negative earnings were reported.
With a Price/Forward Earnings ratio of 9.66, the valuation of ALISP can be described as very reasonable.
69.35% of the companies in the same industry are more expensive than ALISP, based on the Price/Forward Earnings ratio.
ALISP is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.69, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 9.66
ALISP.PA Price Earnings VS Forward Price EarningsALISP.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40 -60

4.2 Price Multiples

70.97% of the companies in the same industry are cheaper than ALISP, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 20.03
ALISP.PA Per share dataALISP.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

ALISP's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as ALISP's earnings are expected to grow with 216.23% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y216.23%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

ALISP does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ISPD NETWORK

EPA:ALISP (9/5/2025, 7:00:00 PM)

1.99

-0.01 (-0.5%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)07-29 2025-07-29
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap29.63M
Analysts86.67
Price Target5.15 (158.79%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-14.89%
EPS NY rev (3m)-14.89%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 9.66
P/S 0.19
P/FCF N/A
P/OCF N/A
P/B 6.17
P/tB N/A
EV/EBITDA 20.03
EPS(TTM)-0.03
EYN/A
EPS(NY)0.21
Fwd EY10.35%
FCF(TTM)-0.43
FCFYN/A
OCF(TTM)-0.32
OCFYN/A
SpS10.48
BVpS0.32
TBVpS-0.55
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.6%
ROE -9.85%
ROCE 3.88%
ROIC 2.85%
ROICexc 4.45%
ROICexgc N/A
OM 0.45%
PM (TTM) N/A
GM 31.54%
FCFM N/A
ROA(3y)2.77%
ROA(5y)1.73%
ROE(3y)30.06%
ROE(5y)N/A
ROIC(3y)13.74%
ROIC(5y)14.58%
ROICexc(3y)49.31%
ROICexc(5y)157.45%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)18.7%
ROCE(5y)19.84%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y-80.84%
ROICexc growth 5YN/A
OM growth 3Y-61.04%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-10.12%
GM growth 5Y-7.49%
F-Score1
Asset Turnover1.99
Health
Industry RankSector Rank
Debt/Equity 1.1
Debt/FCF N/A
Debt/EBITDA 2.7
Cap/Depr 123.02%
Cap/Sales 0.99%
Interest Coverage 1.02
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.95
Quick Ratio 0.95
Altman-Z 2.3
F-Score1
WACC6.34%
ROIC/WACC0.45
Cap/Depr(3y)110.41%
Cap/Depr(5y)81.37%
Cap/Sales(3y)0.96%
Cap/Sales(5y)0.76%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-116.55%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0.22%
EPS Next Y900%
EPS Next 2Y216.23%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)11.47%
Revenue growth 3Y13.88%
Revenue growth 5Y43.98%
Sales Q2Q%6.35%
Revenue Next Year11.17%
Revenue Next 2Y10.79%
Revenue Next 3Y6.89%
Revenue Next 5Y4.86%
EBIT growth 1Y-87.83%
EBIT growth 3Y-55.63%
EBIT growth 5YN/A
EBIT Next Year200%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-48.78%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-76.15%
OCF growth 3YN/A
OCF growth 5YN/A